First-trimester maternal serum screening and the risk for fetal distress during labor

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 2, 2009, Pages 166.e1-166.e6

  Uccella, Stefano ^a   Colombo, Giacomo Filippo ^a   Bulgheroni, Carlo Maria ^a   Serati, Maurizio ^a   Bogani, Giorgio ^a   Salvatore, Stefano ^a   Ghezzi, Fabio ^a   Bolis, Pierfrancesco ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

cesarean section delivery; fetal distress; first trimester screening; nonreassuring fetal status; PAPP A

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ACIDEMIA; ADULT; ARTICLE; BIOCHEMISTRY; CESAREAN SECTION; DOWN SYNDROME; FEMALE; FETUS DISTRESS; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; HYPERTENSION; LABOR; LABOR INDUCTION; MAJOR CLINICAL STUDY; MATERNAL SERUM; PH MEASUREMENT; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCREENING; UMBILICAL ARTERY;

EID: 67651098963     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.05.009     Document Type: Article

References (27)

1. Spencer K., Souter V., Tul N., Snijders R., and Nicolaides K.H. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13 (1999) 231-237
2. Spencer K., Liao A.W., Skentou H., Cicero S., and Nicolaides K.H. Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 20 (2000) 495-499
3. Spencer K., Spencer C.E., Power M., Dawson C., and Nicolaides K.H. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 110 (2003) 281-286
4. Avgidou K., Papageorghiou A., Bindra R., Spencer K., and Nicolaides K.H. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet Gynecol 192 (2005) 1761-1767
5. Nicolaides K.H., Spencer K., Avgidou K., Faiola S., and Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25 (2005) 221-226
6. Breathnach F.M., Malone F.D., Lambert-Messerlian G., et al. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol 110 (2007) 651-657
7. Ball R.H., Caughey A.B., Malone F.D., et al. First- and second-trimester evaluation of risk for Down syndrome. Obstet Gynecol 110 (2007) 10-17
8. Spencer K., Cowans N.J., Avgidou K., Molina F., and Nicolaides K.H. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Ultrasound Obstet Gynecol 31 (2008) 15-19
9. Spencer K., Cowans N.J., Molina F., Kagan K.O., and Nicolaides K.H. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynecol 31 (2008) 147-152
10. Dugoff L., Hobbins J.C., Malone F.D., et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 191 (2004) 1446-1451
11. Spencer K., Cowans N.J., and Nicolaides K.H. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 28 (2008) 7-10
12. Smith G.C., Crossley J.A., Aitken D.A., et al. First-trimester placentation and the risk of antepartum stillbirth. JAMA 292 (2004) 2249-2254
13. Smith G.C., Shah I., Crossley J.A., et al. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 107 (2006) 161-166
14. Goetzl L., Krantz D., Simpson J.L., et al. Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss. Obstet Gynecol 104 (2004) 30-36
15. Nicolaides K.H., Spencer K., Avgidou K., Faiola S., and Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25 (2005) 221-226
16. Ong C.Y., Liao A.W., Spencer K., Munim S., and Nicolaides K.H. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 107 (2000) 1265-1270
17. Spencer K., Ong C.Y., Liao A.W., and Nicolaides K.H. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities. Prenat Diagn 20 (2000) 491-494
18. Spencer K., Bindra R., and Nicolaides K.H. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 23 (2003) 851-855
19. Spencer K., Ong C.Y., Liao A.W., Papademetriou D., and Nicolaides K.H. First trimester markers of trisomy 21 and the influence of maternal cigarette smoking status. Prenat Diagn 20 (2000) 852-853
20. Kwik M., and Morris J. Association between first trimester maternal serum pregnancy associated plasma protein-A and adverse pregnancy outcome. Aust N Z J Obstet Gynaecol 43 (2003) 438-442
21. Royal College of Obstetricians and Gynecologists. The use and interpretation of cardiotocography in intrapartum fetal surveillance: evidence-based clinical guideline no. 8. www.rcog.org.uk Accessed Jan. 1, 2009
22. Lawrence J.B., Oxvig C., Overgaard M.T., et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96 (1999) 3149-3153
23. Cowans N.J., and Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 27 (2007) 264-271
24. Smith G.C., Stenhouse E.J., Crossley J.A., Aitken D.A., Cameron A.D., and Connor J.M. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 87 (2002) 1762-1767
25. Kniss D.A., Shubert P.J., Zimmerman P.D., Landon M.B., and Gabbe S.G. Insulinlike growth factors: their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. J Reprod Med 39 (1994) 249-256
26. Clemmons D.R. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol 140 (1998) 19-24
27. MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 319 (1999) 1054-1059